Effect of autohemotherapy in the treatment of viral infections - a systematic review

Effect of autohemotherapy in the treatment of viral infections - a systematic review

To analyze the literature to determine whether autohemotherapy has any effect either clinically or on the immune system on viral diseases on the last ten years. Systematic review. Searches from the year 2010, with at least 5 patients were conducted in PubMed/MEDLINE, Embase, Scopus, Cochrane, LILACS...

Full description

Saved in:
Bibliographic Details
Published in:Public health (London) Vol. 201; pp. 78 - 88
Main Authors: Niño-Sandoval, T.C., Rocha, N.S., Sarinho, F.W., Vasconcelos, C.F. de M., Vasconcelos, A.F. de M., Vasconcelos, B.C.
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01-12-2021
Elsevier Science Ltd
Subjects:
Autohemotherapy
Comparative studies
Coronavirus
Coronavirus Infections
Coronaviruses
COVID-19
Hepatitis
Hepatitis B
Hepatitis C
Humans
Immune system
Literature reviews
Medical treatment
Prospective Studies
Review
Searching
Signs and symptoms
Systematic review
Systematic Reviews as Topic
Viral diseases
Viral infections
Virus Diseases - therapy
Viruses
COVID-19
Hepatitis
Coronavirus
Autohemotherapy
Review
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To analyze the literature to determine whether autohemotherapy has any effect either clinically or on the immune system on viral diseases on the last ten years. Systematic review. Searches from the year 2010, with at least 5 patients were conducted in PubMed/MEDLINE, Embase, Scopus, Cochrane, LILACS, SciELO, and Web of Science databases. Hand searches were performed in systematic reviews and literature reviews related to autohemotherapy. Unpublished manuscripts were hand-searched in specialized journals. Eight articles were included. Hepatitis B virus, hepatitis C virus, and Coronavirus were evaluated. Autohemotherapy had good results in hepatitis C, hepatitis B, and Coronavirus. Autohemotherapy is a safe practice that improves symptoms in the treatment of hepatitis B virus, hepatitis C virus, and Coronavirus. It is necessary to perform more prospective comparative studies with homogeneous protocols.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0033-3506
1476-5616
DOI:10.1016/j.puhe.2021.09.024